Opdivo (nivolumab) - Ono Pharma, BMS
|
Autologous DC and NK Cells - First Hospital of China Medical University
|
Keytruda (pembrolizumab) - Merck (MSD)
|
Baize’an (tislelizumab) - BeiGene, Novartis
|
AiRuiKa (camrelizumab) - Jiangsu Hengrui Pharma
|
Tuoyi (toripalimab) - Shanghai Junshi Biosci, Coherus Biosci
|
Tyvyt (sintilimab) - Eli Lilly
|